Диссертация (1140250), страница 21
Текст из файла (страница 21)
Hamrahian S.M. Management of Hypertension in Patients with ChronicKidney Disease // Can J Cardiol. – 2017.- Vol.33, №5.- Р. 557-576105. Hamrahian S.M, Falkner B. Hypertension in Chronic Kidney Disease // AdvExp Med Biol. - 2016.106. HeringD., TrzebskiA., NarkiewiczK.Recentadvancesinthepathophysiology of arterial hypertension: potential implications for clinicalpractice // Pol Arch Intern Med.
– 2017.- Vol.127, №3.- Р.195-204.107. Heerspink H.J., Desai M., Jardine M., Balis D., Meininger G., Perkovic V.Canagliflozin slows progression of renal function decline independently ofglycemic effects // J Am Soc Nephrol.- 2017.- Vol. 28.- Р. 368–375.108. Hill N.R., Fatoba S.T., Oke J.L,. et al. Global prevalence of chronic kidneydisease—a systematic review and meta-analysis // PLoS One.-2016.- Vol.11.- e0158765.109. Hippisley-CoxJ., CouplandC.Predicting the riskof chronicKidneyDisease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores // BMC Fam Pract.
– 2010.- P.11-49.110. Hou W., Lv J., Perkovic V., et al. Effect of statin therapy on cardiovascular andrenal outcomes in patients with chronic kidney disease: a systematic review andmeta-analysis // Eur Heart J.- 2013.- Vol. 34.- Р. 1807–1817.130111. Jager K.J., Fraser S.D.S. The ascending rank of chronic kidney disease in theglobal burden of disease study // Nephrol Dial Transplant.
– 2017.- Vol.32(suppl2).-ii121-ii128.112. Jafar T.H., Allen J.C., Jehan I., et al. Health education and general practitionertraining in hypertension management: long-term effects on kidney function // ClinJ Am Soc Nephrol.- 2016.- Vol. 11.- Р. 1044–1053.113. JamesM.T., GramsM.E., WoodwardM., ElleyC.R., GreenJ.A., CKDPrognosis Consortium. A Meta-analysis of the Association of EstimatedGFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute KidneyInjury // Am J Kidney Dis. – 2015.- Vol.66, №4.- Р.602-612.114.
Jha V., Garcia-Garcia G., Iseki K., et al. Chronic kidney disease: globaldimension and perspectives // Lancet.- 2013.- Vol. 382.- Р. 260–272.115. Jolly S.E., Navaneethan S.D., Schold J.D., Arrigain S., Konig V., BurruckerY.K., Hyland J., Dann P., Tucky B.H., Sharp J.W., Nally J.V. Development of achronic kidney disease patient navigator program // BMC Nephrol. – 2015.Vol.16.- Р.69.116. JohnsonD.W., JonesG.R., MathewT.H., LudlowM.J.Chronickidney disease and automatic reporting of estimated glomerular filtration rate: newdevelopments and revised recommendations // Med J Aust.- 2012.- Vol.
197, №4.Р.224-225117. Johnson E.S., Thorp M.L., Platt R.W., Smith D.H. Predicting the risk ofdialysis and transplant among patients with CKD: a retrospective cohort study //Am J Kidney Dis. – 2008.- Vol. 52.- Р. 653-660.118. Johnson E.S., Thorp M.L., Yang X., Charansonney O.L., Smith D.H.Predicting renal replacement therapy and mortality in CKD // Am J Kidney Dis.2007.- Vol. 50.- Р. 559-565.119. Judd E., Calhoun D.A. Management of hypertension in CKD: beyond theguidelines // Adv Chronic Kidney Dis.
– 2015.- Vol.22, №2.- Р.116-122.131120. Jun M., Hemmelgarn B.R. Strategies for BP control in developing countriesand effects on kidney function // Clin J Am Soc Nephrol.- 2016.- Vol. 11.- Р. 932–34.121. Kalantar-Zadeh K., Unruh M. Health related quality of life in patients withchronic kidney disease // Int Urol Nephrol.
– 2005.- Vol.37, №2.- Р.367-378.122. KDIGO Clinical Practice Guideline for Glomerulonephritis // KidneyInternational Supplements.- 2012, № 2.- Р. 259–274.123. Keane W.F., Zhang Z., Lyle P.A., Cooper M.E., de Zeeuw D., Grunfeld J.P., etal. Risk scores for predicting outcomes in patients with type 2 diabetes andnephropathy: the RENAAL study // Clin J Am Soc Nephrol. – 2006.- Vol.1.- Р.761-767.124. Khatib R., McKee M., Shannon H., et al. Availability and affordability ofcardiovascular disease medicines and their effect on use in high-income, middleincome, and low-income countries: an analysis of the PURE study data // Lancet.2016.- Vol.
387.- Р. 61–69.125. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group.KDIGO Clinical Practice Guideline for Lipid Management in Chronic KidneyDisease // Kidney Int. (Suppl.). – 2013. – Vol. 3. – P. 259–305.126. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group.KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease //Kidney Inter. (Suppl.).
– 2012., № 2.127. KidneyDisease: Improving Global Outcomes (KDIGO) Blood Pressure WorkGroup. KDIGO Clinical Practice Guideline for the Management of Blood Pressurein Chronic Kidney Disease // Kidney Int.- 2012.- Т. 2., № 5.128. Kramer H., Palmas W., Kestenbaum B., et al. Chronic kidney diseaseprevalence estimates among racial/ethnic groups: the multi-ethnic study ofatherosclerosis // Clin J Am Soc Nephrol.- 2008- Vol. 3.- Р. 1391–97.132129. Kshirsagar A.V., Bang H., Bomback A.S., Vupputuri S., Shoham D.A., KernL.M., KlemmerP.J., MazumdarM., AugustP.A.A simple algorithm to predict incident kidney disease // Arch Intern Med.- 2008.Vol.168, №22.- Р.2466-2473.130. Kulenthiran S., Ewen S., Böhm M., Mahfoud F.
Hypertension up to date:SPRINT to SPYRAL // Clin Res Cardiol. - 2017 Mar 22.131. Kuznik A., Mardekian J., Tarasenko L. Evaluation of cardiovascular diseaseburden and therapeutic goal attainment in US adults with chronic kidney disease:an analysis of national health and nutritional examination survey data, 2001-2010.// BMC Nephrol.- 2013. -Т. 14, № 1.- С.132132. Kwon K.S., Bang H., Bomback A.S., Koh D.H., Yum J.H., Lee J.H., LeeS., Park S.K., Yoo K.Y., Park S.K., Chang S.H., Lim H.S., Choi J.M., KshirsagarA.V.
A simple prediction score for kidney disease in the Korean population //Nephrology (Carlton). – 2012.- Vol.17, №3.- Р.278-284.133. Quack I., Westenfeld R. Cardiovascular morbidity and mortality in patientswith kidney disease // Dtsch Med Wochenschr.
– 2016.- Vol.141, №24.- Р.17711776.134. Qaseem A. Screening, monitoring, and treatment of stage 1 to 3 chronic kidneydisease: A clinical practice guideline from the American College of Physicians. //Ann. Intern. Med. - 2013. -Т. 159, № 12.- С. 835–47.135. Landray M.J., Emberson J.R., Blackwell L., Dasgupta T., Zakeri R., MorganM.D., et al. Prediction of ESRD and death among people with CKD: the ChronicRenal Impairment in Birmingham (CRIB) prospective cohort study // Am J KidneyDis.
– 2010.- Vol. 56.- Р.1082-1094.136. Lee H., Manns B., Taub K., et al. Cost analysis of ongoing care of patients withend-stage renal disease: the impact of dialysis modality and dialysis access // Am JKidney Dis.- 2002.- Vol. 40.- Р. 611–622.133137. Leem J., Lee I.K. Mechanisms of Vascular Calcification: The Pivotal Role ofPyruvate Dehydrogenase Kinase 4 // Endocrinol Metab (Seoul).
– 2016.- Vol. 31,№1.- Р.52-61.138. Lerner B., Desrochers S., Tangri N. Risk Prediction Models in CKD // SeminNephrol.- 2017.- Vol.37, №2.- Р.144-150.139. Levey A.S., Stevens L.A., Coresh J. Conceptual Model of CKD: Applicationsand Implications // American Journal of Kidney Diseases.- 2009.- Vol.3 (3 Suppl3).-Р. 4-16140. Levey A.S., Cattran D., Friedman A., Miller W.G., Sedor J., Tuttle K,. KasiskeB., Hostetter T. Proteinuria as a surrogate outcome in CKD: report of a scientificworkshop sponsored by the National Kidney Foundation and the US Food andDrug Administration // Am J Kidney Dis.
– 2009.- Vol.54, №2.- Р.205-226.141. Levin A., Tonelli M., Bonventre J., Coresh J., Donner J.A., Fogo A.B., FoxC.S., GansevoortR.T., HeerspinkH.J.L., JardineM.etal.Global kidney health 2017 and beyond: roadmap for closing gaps in care, research,and policy // Lancet. - 2017.- pii: S0140-6736(17)30788-2.142.
Liaño F. и др. Prognosis of acute tubular necrosis: an extended prospectivelycontrasted study. // Nephron. 1993. Т. 63. № 1. С. 21–31.143. Lins R.L. и др. Prognostic value of a new scoring system for hospital mortalityin acute renal failure. // Clin. Nephrol. 2000. Т. 53. № 1. С. 10–7.144. Liyanage T., Ninomiya T., Jha V., et al. Worldwide access to treatment forend-stage kidney disease: a systematic review // Lancet.- 2015.- Vol. 385.- Р.1975–1982.145. Lins R.L.
и др. Re-evaluation and modification of the Stuivenberg HospitalAcute Renal Failure (SHARF) scoring system for the prognosis of acute renalfailure: an independent multicentre, prospective study. // Nephrol. Dial. Transplant.2004. Т. 19. № 9. С. 2282–8.134146. Liu X., Liu X., Huang W., Leo S., Li Y., Liu M., Yuan H.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
